Health Care & Life Sciences » Biotechnology | Keryx Biopharmaceuticals Inc.

Keryx Biopharmaceuticals Inc. | Mutual Funds

Mutual Funds that own Keryx Biopharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
SPDR S&P Biotech ETF
2,541,090
2.11%
6,537
0.15%
09/06/2018
Vanguard Small Cap Index Fund
2,275,568
1.89%
36,316
0.01%
07/31/2018
Vanguard Total Stock Market Index Fund
2,177,438
1.81%
0
0%
07/31/2018
Government Pension Fund - Global (The)
2,051,898
1.7%
349,963
0%
12/31/2017
ClearBridge Special Investment Trust
2,038,160
1.69%
0
0.59%
01/31/2018
iShares Russell 2000 ETF
1,978,305
1.64%
-1,056
0.01%
09/06/2018
Vanguard Extended Market Index Fund
1,428,090
1.19%
0
0.01%
07/31/2018
Vanguard Small Cap Growth Index Fund
1,294,518
1.08%
18,246
0.02%
07/31/2018
iShares Russell 2000 Growth ETF
920,807
0.76%
0
0.03%
09/06/2018
Ohio National - Capital Growth Portfolio
494,600
0.41%
-47,780
0.59%
03/31/2018

About Keryx Biopharmaceuticals

View Profile
Address
12th Floor
Boston Massachusetts 02210
United States
Employees -
Website http://www.keryx.com
Updated 09/14/2018
Keryx Biopharmaceuticals, Inc. engages in the manufacture, development, and commercialization of medicines for use in treating human diseases. Its product is the Auryxia tablet. The company was founded in October 1998 and is headquartered in Boston, MA.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.